Read More Pharma Industry News ABL Bio, Sanofi sign $1bn deal for Parkinson’s candidate ABL301 ABL Bio has bagged a global collaboration and licensing deal worth up to $1.06 billion with Sanofi to… bySrinathJanuary 14, 2022
